MEDEYE Publishers adheres to the highest ethical standards in scholarly publishing, following the guidelines set by:
ICMJE (International Committee of Medical Journal Editors)
COPE (Committee on Publication Ethics)
WAME (World Association of Medical Editors)
Manuscripts must be original and should not be under consideration elsewhere.
Plagiarism detection software (Turnitin/iThenticate) is used before acceptance.
Text similarity must not exceed 19%, excluding references.
Al plagiarism should not exceed 30%, and the sections where AI assistance was utilized should be mentioned.
Studies involving human subjects must have IRB/Ethics Committee approval and comply with the Helsinki Declaration.
1Clinical trials must be registered in an internationally recognized database (e.g., ClinicalTrials.gov/ https://ctr.dra.gov.pk/ ).
Authors must declare all potential financial, institutional, or personal conflicts.
All funding sources must be disclosed in the manuscript.
Manuscripts are evaluated solely based on academic merit, free from commercial influence.
Editors must not be involved in decisions about their own work submitted to the journal.
Editors must not disclose manuscript details to anyone except the author(s) and reviewers.
Editors must recuse themselves from handling a manuscript if a conflict of interest exists.
MedEye Publishers follows a double-blind peer review process to ensure impartiality.
Reviews should be objective, constructive, and free from personal criticism.
If a reviewer has a conflict of interest, they must decline the review request.
Manuscripts are screened for scope, formatting, and plagiarism compliance.
At least two expert reviewers evaluate the manuscript.
Accepted: Minor revisions required.
Minor Revisions: Authors must revise based on feedback.
Major Revisions: Extensive changes needed; may require a second review.
Rejected Manuscript does not meet the journal's standards.
Authors can opt for an expedited review process with a decision within
2-4 weeks.
Additional fees may apply for rapid processing.
MedEye Publishers supports Open Access (OA) to enhance global knowledge dissemination.
Authors retain copyright and publish under Creative Commons licenses
(CC BY 4.0 or CC BY-NC 4.0).
Articles are freely available for reading, sharing, and adaptation.
Transparent Pricing: APCs cover editorial processing,
production, and hosting.
Waivers & Discounts: Available for authors from low-income countries.
Authors retain copyright but grant MedEye Publishers a license to
publish and distribute their work.
All published articles will be freely available under Open Access terms.
Formatting: Manuscripts should follow the journal-specific
formatting requirements.
A structured abstract (Objectives, Methods, Results, Conclusion) must be included.
Language & Style: Manuscripts must be in clear, scholarly
English.
Non-native authors should seek professional editing services before submission.
References: Recent (last 5 years) references must be used, formatted in Vancouver or APA style.
Online Submission System: All manuscripts must be submitted via the MedEye Publishers online portal.
Cover Letter Requirement: A cover letter explaining the study's significance must be included.
Acknowledgment & Tracking: Authors receive an email confirmation
upon successful submission.
Manuscripts can be tracked through the submission system.
MedEye Publishers follows COPE’s guidelines for handling research integrity issues.
Plagiarism: Copying others’ work without proper citation.
Data Fabrication/Falsification: Manipulating data to mislead readers.
Duplicate Submission: Submitting the same work to multiple journals.
Minor infractions: Authors may be asked to revise the manuscript.
Serious infractions: May result in retraction, institutional reporting, and author blacklisting.
MedEye Publishers follows COPE Retraction Guidelines for handling post-publication issues.
Errata: For minor errors that do not impact conclusions.
Retractions: For serious errors or misconduct.
Expressions of Concern: When further investigation is required.
No advertisements that conflict with the scientific integrity of MedEye
Publishers' journals.
Sponsored content must be clearly labeled as such.
MedEye Publishers complies with GDPR regulations to protect author and
user data.
Personal information will never be shared without consent.
📧 Email: editor@medeyepublishers.com
🌍 Website: www.medeyepublishers.com